Clinical Trial: A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food of SYH2056 in Healthy Subjects

U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07771777) titled 'A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food of SYH2056 in Healthy Subjects' on May 14.

Brief Summary: This is a single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, PK characteristics, and food effect of single ascending oral doses of SYH2056 tablets in healthy participants. The study is planned to have two Parts: Part 1 [the single ascending dose (SAD) study] and Part 2 (the food effect study).

Study Start Date: Aug. 30

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: SYH2056 tablet...